Skip to main content
Equibles

ZLDPF · Zealand Pharma A/S/ADR · Investor Relations

Track ZLDPF — free

Use ZLDPF with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$46.38 At close · Sep 8
Rebalance outlook locked
Market Cap
$3.22B
Shares
67.66M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-08-13 H1 Financial Results / Interim Report First Half 2026 Earnings call
2026-06-09 Goldman Sachs Global Healthcare Conference 2026 (Miami) Conference
2026-06-03 Jefferies Global Healthcare Conference 2026 (New York) Conference
2026-05-07 Q1 Financial Results / Interim Report First Quarter 2026 Earnings call
2026-03-11 Barclays 28th Annual Global Healthcare Conference (Miami) Conference
2026-03-05 Zealand Pharma topline results from Phase 2 ZUPREME-1 trial for petrelintide Earnings call
2026-02-19 Q4 Financial Results / Annual Report 2025 Earnings call
2026-01-14 J.P. Morgan Healthcare Conference (San Francisco) Conference
2025-12-11 Capital Markets Day 2025 Webcast
2025-11-19 Jefferies Global Healthcare Conference (London) Conference
2025-11-13 Zealand Pharma Interim Report Q3 2025 Earnings call
2025-09-25 Bank of America 2025 Global Healthcare Conference (London) Conference
2025-09-04 Cantor Global Healthcare Conference (New York) Conference
2025-08-14 Zealand Pharma Interim Report H1 2025 Earnings call
2025-06-11 Goldman Sachs Annual Global Healthcare Conference (Miami) Conference
2025-05-14 Bank of America Global Healthcare Conference (Las Vegas) Conference
2025-05-08 Zealand Pharma Interim Report Q1 2025 Earnings call
2025-03-12 Zealand Pharma conference call on collaboration and license agreement with Roche to co-develop and co-commercialize petrelintide Conference
2025-02-20 Zealand Pharma Annual Report 2024 Webcast
2024-11-07 Zealand Pharma Interim Report Q3 2024 Earnings call
2024-08-15 Zealand Pharma Interim Report H1 2024 Event
2024-06-20 Zealand Pharma topline results for Phase 1b trial of petrelintide Event
2024-05-16 Zealand Pharma Interim Report Q1 2024 Event
2024-02-27 Zealand Pharma Annual Report 2023 Event
2023-12-05 Zealand Pharma’s Obesity R&D Event Event

Source: https://www.zealandpharma.com/investors

Key facts CIK 2068427 Visit website Investor relations